290 related articles for article (PubMed ID: 21731750)
1. DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.
Selamat SA; Galler JS; Joshi AD; Fyfe MN; Campan M; Siegmund KD; Kerr KM; Laird-Offringa IA
PLoS One; 2011; 6(6):e21443. PubMed ID: 21731750
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation profile during multistage progression of pulmonary adenocarcinomas.
Chung JH; Lee HJ; Kim BH; Cho NY; Kang GH
Virchows Arch; 2011 Aug; 459(2):201-11. PubMed ID: 21494759
[TBL] [Abstract][Full Text] [Related]
3. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ.
Xu X; Li N; Zhao R; Zhu L; Shao J; Zhang J
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2447-2453. PubMed ID: 28821955
[TBL] [Abstract][Full Text] [Related]
4. Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma.
Tsou JA; Galler JS; Siegmund KD; Laird PW; Turla S; Cozen W; Hagen JA; Koss MN; Laird-Offringa IA
Mol Cancer; 2007 Oct; 6():70. PubMed ID: 17967182
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH
Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung.
Licchesi JD; Westra WH; Hooker CM; Herman JG
Clin Cancer Res; 2008 May; 14(9):2570-8. PubMed ID: 18451218
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation profiling identifies the HOXA11 gene as an early diagnostic and prognostic molecular marker in human lung adenocarcinoma.
Li Q; Chen C; Ren X; Sun W
Oncotarget; 2017 May; 8(20):33100-33109. PubMed ID: 28380439
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary preinvasive neoplasia.
Kerr KM
J Clin Pathol; 2001 Apr; 54(4):257-71. PubMed ID: 11304841
[TBL] [Abstract][Full Text] [Related]
10. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma.
Sato T; Arai E; Kohno T; Tsuta K; Watanabe S; Soejima K; Betsuyaku T; Kanai Y
PLoS One; 2013; 8(3):e59444. PubMed ID: 23544068
[TBL] [Abstract][Full Text] [Related]
12. Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas.
Hu X; Estecio MR; Chen R; Reuben A; Wang L; Fujimoto J; Carrot-Zhang J; McGranahan N; Ying L; Fukuoka J; Chow CW; Pham HHN; Godoy MCB; Carter BW; Behrens C; Zhang J; Antonoff MB; Sepesi B; Lu Y; Pass HI; Kadara H; Scheet P; Vaporciyan AA; Heymach JV; Wistuba II; Lee JJ; Futreal PA; Su D; Issa JJ; Zhang J
Nat Commun; 2021 Jan; 12(1):687. PubMed ID: 33514726
[TBL] [Abstract][Full Text] [Related]
13. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
Awaya H; Takeshima Y; Furonaka O; Kohno N; Inai K
J Clin Pathol; 2005 Oct; 58(10):1076-80. PubMed ID: 16189154
[TBL] [Abstract][Full Text] [Related]
14. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
15. Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression.
Ibrahim AE; Arends MJ; Silva AL; Wyllie AH; Greger L; Ito Y; Vowler SL; Huang TH; Tavaré S; Murrell A; Brenton JD
Gut; 2011 Apr; 60(4):499-508. PubMed ID: 21068132
[TBL] [Abstract][Full Text] [Related]
16. Increased expressions of claudin 4 and 7 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
Yamada G; Murata M; Takasawa A; Nojima M; Mori Y; Sawada N; Takahashi H
Med Mol Morphol; 2016 Sep; 49(3):163-9. PubMed ID: 26872891
[TBL] [Abstract][Full Text] [Related]
17. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.
Hu X; Fujimoto J; Ying L; Fukuoka J; Ashizawa K; Sun W; Reuben A; Chow CW; McGranahan N; Chen R; Hu J; Godoy MC; Tabata K; Kuroda K; Shi L; Li J; Behrens C; Parra ER; Little LD; Gumbs C; Mao X; Song X; Tippen S; Thornton RL; Kadara H; Scheet P; Roarty E; Ostrin EJ; Wang X; Carter BW; Antonoff MB; Zhang J; Vaporciyan AA; Pass H; Swisher SG; Heymach JV; Lee JJ; Wistuba II; Hong WK; Futreal PA; Su D; Zhang J
Nat Commun; 2019 Jul; 10(1):2978. PubMed ID: 31278276
[TBL] [Abstract][Full Text] [Related]
18. Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA.
Izumchenko E; Chang X; Brait M; Fertig E; Kagohara LT; Bedi A; Marchionni L; Agrawal N; Ravi R; Jones S; Hoque MO; Westra WH; Sidransky D
Nat Commun; 2015 Sep; 6():8258. PubMed ID: 26374070
[TBL] [Abstract][Full Text] [Related]
19. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas.
Sakamoto H; Shimizu J; Horio Y; Ueda R; Takahashi T; Mitsudomi T; Yatabe Y
J Pathol; 2007 Jul; 212(3):287-94. PubMed ID: 17534846
[TBL] [Abstract][Full Text] [Related]
20. Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development.
Shimada A; Kano J; Ishiyama T; Okubo C; Iijima T; Morishita Y; Minami Y; Inadome Y; Shu Y; Sugita S; Takeuchi T; Noguchi M
Cancer Sci; 2005 Oct; 96(10):668-75. PubMed ID: 16232198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
